Illumina launches collaboration with the New York Genome Center; Baxano completes enrollment for spinal stenosis treatment study;

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Baxano, a Silicon Valley-based medical device company, has completed enrollment in a post-market clinical study of its iO-Flex surgical system, which helps decompress patients with moderate to severe lumbar spinal stenosis. Release

> New genetic tests and better surgical techniques are poised to improve how teenagers with scoliosis are treated, The Wall Street Journal reports. Blog

> A robotic-assisted radical prostatectomy costs $6,000 more than open procedures and appears to be a money loser, according to a preliminary study from a major hospital presented at the American Urological Association meeting. Story

> The New York Genome Center has launched its formal collaborative relationship with gene sequencing company Illumina ($ILMN). Release

> Intermountain Healthcare and Myriad Genetics have inked a deal to research and test molecular diagnostic tests Myriad has under development focused on prostate cancer and other diseases. Release

Biotech News

 @FierceBiotech: Chasing a holy grail in pharma, Novo confident that it can crack blockbuster oral insulin market. More | Follow @FierceBiotech

 @JohnCFierce: Top biotechs boosted R&D spending 13% last year, and trend still points north. Special Report on biggest R&D spenders. More | Follow @JohnCFierce

 @RyanMFierce: Pfizer is offering heart-healthy recipes via a mobile app. The message: Eat well, take Lipitor. More | Follow @RyanMFierce

> GSK tweaks Human Genome bid to include poison pill antidote. More

> InterMune deal delivers $55M in fresh fuel for fibrosis drug. News

> French biotechs afflicted by a plunge in financial support. Story

Pharma News

 @FiercePharma:  Counterfeit drugs threaten strides against malaria; Some companies trying text technology to combat fakes. More | Follow @FiercePharma

> Pfizer adds healthy-eating app to Lipitor marketing arsenal. More

> Merck CEO assures shareholders there is life after death of Singulair patent. News

> New use for Humira delayed as Abbott preps for spinoff. Article

Drug Delivery News

 @DamianFierce: Prosonix says its new delivery platform makes combined APIs more effective: Story | Follow @DamianFierce

> Impax cited by FDA in manufacturing inspection. Story

> Boehringer gets positive PhII for COPD inhalant. Article

> BDSI snags $2.5M milestone from Meda. News

Biomarkers News

> HDL isn't clear-cut biomarker, study suggests. News

> Gut microbe signature could tag radiation exposure. Story

> Blood test for bowel cancer is in the DNA. More

> Are you hungry? Biomarker spots preemies ready to feed. Article

And Finally... An Irish model is speaking out in favor of tougher regulation for the cosmetic surgery industry after dealing with ruptured implants from Poly Implant Prostheses, the now-defunct French company that revealed it had sold sub-standard implants in Europe and elsewhere for years. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.